PRAX
PraxisยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PRAX Profile
Praxis Precision Medicines, Inc.
A clinical-stage biopharmaceutical company that developing therapies for central nervous system disorders
Biological Technology
09/22/2015
10/16/2020
NASDAQ Stock Exchange
116
12-31
Common stock
99 High Street, 30th Floor, Boston, MA, 02110
--
Praxis Precision Medicines, Inc., was incorporated under the laws of the State of Delaware on September 22, 2015. The company is a clinical-stage biopharmaceutical company that translates genetic insights into the development of treatments for the central nervous system (CNS), a disease characterized by neuronal imbalance.
